| 2023-02-02 | name changed from c.3528delC to c.3528del |
Variant NM_000492.4:c.3528del
| Name | NM_000492.4:c.3528del |
| Protein name | NP_000483.3:p.(Lys1177Serfs*15) |
| Genomic name (hg19) | chr7:g.117267635del UCSC |
| Genomic name (hg38) | chr7:g.117627581del UCSC |
| #Exon/intron | exon 22 |
| Legacy Name | 3659delC |
| Class | disease-causing |
| Subclass | CF-causing |
| WT sequence | ACATGCCAACAGAAGGTAAACCTAC C AAGTCAACCAAACCATACAAGAATG |
| Mutant sequence | ACATGCCAACAGAAGGTAAACCTAC - AAGTCAACCAAACCATACAAGAATG |
![]() |
![]() | dbSNP rs121908747 |
![]() Not found | ![]() |
| Reference | PMID | Modulator | in vitro / ex vivo data | clinical data | Patient responsiveness |
| Burgel et al., 2024 | 39151434 | ELX-TEZ-IVA | N.D. | yes | no |
No patient found in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 31 |
|---|---|
| Asymptomatic compound heterozygote | 1 |
| CF | 26 |
| CFTR-RD | 1
|
| Fetal bowel anomalies | 1 |
| Pending | 2 |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| Pending | 4819 | heterozygote | |
| Pending | 2228 | heterozygote | CFTR-RD-causing- Undef |
| CF | 2029 | heterozygote | CF-causing - Trans |
| CF | 3481 | heterozygote | CF-causing- Undef |
| CF | 3603 | heterozygote | CF-causing- Undef |
| CF | 3839 | heterozygote | CF-causing- Undef |
| CF | 4381 | heterozygote | CF-causing- Undef |
| CF | 4413 | heterozygote | CF-causing - Trans |
| CF | 4443 | heterozygote | CF-causing - Trans |
| CF | 4460 | heterozygote | CF-causing - Trans |
| CF | 4496 | heterozygote | CF-causing - Trans |
| CF | 4538 | heterozygote | CFTR-RD-causing - Trans CF-causing - Trans |
| CF | 1975 | heterozygote | CF-causing- Undef |
| CF | 1933 | heterozygote | CF-causing- Undef |
| CF | 1790 | heterozygote | CF-causing- Undef |
| CF | 209 | heterozygote | CF-causing- Undef |
| CF | 303 | heterozygote | CF-causing - Trans |
| CF | 365 | heterozygote | CF-causing - Trans |
| CF | 368 | heterozygote | CF-causing - Trans |
| CF | 502 | heterozygote | CF-causing- Undef |
| CF | 953 | heterozygote | CF-causing - Trans |
| CF | 989 | heterozygote | CF-causing- Undef |
| CF | 5227 | heterozygote | CF-causing - Trans |
| CF | 5526 | heterozygote | CF-causing - Trans |
| CF | 1086 | heterozygote | CF-causing- Undef |
| CF | 1629 | heterozygote | CF-causing- Undef |
| CF | 1717 | heterozygote | CF-causing- Undef |
| CF | 6525 | heterozygote | non-CF- Undef |
| CBAVD | 1308 | heterozygote | CFTR-RD-causing- Undef |
| Fetal bowel anomalies | 4802 | heterozygote | |
| Asymptomatic compound heterozygote | 4345 | heterozygote |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|